GLP-1, Weight Regain, and the WHO: What “Progressive and Relapsing” Actually Means
When the World Health Organization (WHO) released its GLP-1 guidelines, most people focused on access and prescribing. What went largely unnoticed was a shift in language that changes how obesity—and weight regain—are understood. This post breaks down what “chronic, progressive, and relapsing” actually means for women navigating long-term use of GLP-1 medications like Zepbound, Wegovy, Mounjaro, and Ozempic.